✦ LIBER ✦

First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study

✍ Scribed by Thomssen, Christoph; Pierga, Jean-Yves; Pritchard, Kathleen I.; Biganzoli, Laura; Cortes-Funes, Hernan; Petráková, Katarína; Kaufman, Bella; Duenne, Anja; Smith, Ian

Book ID: 119962236
Publisher: S. Karger AG
Year: 2012
Tongue: English
Weight: 375 KB
Volume: 82
Category: Article
ISSN: 0030-2414
DOI: 10.1159/000336892

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line bevacizumab-containing therap

First-line bevacizumab-containing therapy for breast cancer: results in patients aged >=70 years treated in the ATHENA study

✍ Biganzoli, L.; Di Vincenzo, E.; Jiang, Z.; Lichinitser, M.; Shen, Z.; Delva, R.; 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 185 KB

Second-line bevacizumab-containing thera

Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial

✍ Adam Brufsky, Vicente Valero, Beatrice Tiangco, Shaker Dakhil, Arija Brize, Hope 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 402 KB

5073 POSTER Bevacizumab (Bev) Combined W

5073 POSTER Bevacizumab (Bev) Combined With Paclitaxel (Pac) as First-line Therapy for Metastatic Triple-negative Breast Cancer (TNBC) -Analysis of 147 Patients (pts) Treated in Routine Oncology Practice in Germany

✍ Schneeweiss, A.; Foerster, F.; Hollburg, W.; Tesch, H.; Klare, P.; Wuelfing, P.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Final results of a phase II study ofnab-

Final results of a phase II study ofnab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

✍ Christopher Lobo; Gilberto Lopes; Odalys Baez; Aurelio Castrellon; Annapoorna Fe 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 268 KB

A prognostic factor index for overall su

A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial

✍ Llombart-Cussac, Antonio; Pivot, Xavier; Biganzoli, Laura; Cortes-Funes, Hernan; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 725 KB

The efficacy and safety of gemcitabine p

The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype

✍ Kenjiro Aogi; Masayuki Yoshida; Yoshiaki Sagara; Shunji Kamigaki; Minoru Okazaki 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 311 KB